Diabetes, Vol 36, Issue 7 808-812, Copyright © 1987 by American Diabetes Association

ARTICLES

Progression of incipient diabetic retinopathy during good glycemic control

RL Engerman and TS Kern

To assess the extent to which the progression of diabetic retinopathy can be arrested by improved glycemic control, 35 normal dogs were randomly divided into a nondiabetic and three alloxan-induced diabetic groups prospectively identified according to glycemic control: poor control for 5 yr (PC), good control for 5 yr (GC), and poor control for 2.5 yr followed by good control for 2.5 yr (PGC). To achieve good control, insulin was given twice daily together with a measured diet so that hyperglycemia and glucosuria were mild and infrequent, and HbA1 was comparable to normal. Retinal capillary aneurysms and other lesions developed during 60 mo of poor control (group PC) and were inhibited if good control was begun promptly within 2 mo (group GC). In group PGC, retinopathy was absent or equivocal at 2.5 yr of poor control and, surprisingly, was found to develop subsequently despite good glycemic control. Retinopathy in group PGC was greater at autopsy than at 2.5 yr and was greater than in group GC. The results indicate that retinopathy may be preventable but tends to resist arrest even in its incipient stages, before more than the first few aneurysms have appeared.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. A. Kowluru, M. Kanwar, P.-S. Chan, and J. P. Zhang Inhibition of Retinopathy and Retinal Metabolic Abnormalities in Diabetic Rats With AREDS-Based Micronutrients Arch Ophthalmol, September 1, 2008; 126(9): 1266 - 1272. [Abstract] [Full Text] [PDF]

				K. Hietala, C. Forsblom, P. Summanen, P.-H. Groop, and on behalf of the FinnDiane Study Group Heritability of Proliferative Diabetic Retinopathy Diabetes, August 1, 2008; 57(8): 2176 - 2180. [Abstract] [Full Text] [PDF]

				J. Chen, X. Huang, D. Halicka, S. Brodsky, A. Avram, J. Eskander, N. A. Bloomgarden, Z. Darzynkiewicz, and M. S. Goligorsky Contribution of p16INK4a and p21CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53 Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1575 - H1586. [Abstract] [Full Text] [PDF]

				P. Suryanarayana, M. Saraswat, T. Mrudula, T. P. Krishna, K. Krishnaswamy, and G. B. Reddy Curcumin and Turmeric Delay Streptozotocin-Induced Diabetic Cataract in Rats Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2092 - 2099. [Abstract] [Full Text] [PDF]

				R. N. Frank Diabetic Retinopathy N. Engl. J. Med., January 1, 2004; 350(1): 48 - 58. [Full Text] [PDF]

				M. Cusick, E. Y. Chew, F. Ferris III, T. A. Cox, C.-C. Chan, and P. F. Kador Effects of Aldose Reductase Inhibitors and Galactose Withdrawal on Fluorescein Angiographic Lesions in Galactose-Fed Dogs Arch Ophthalmol, December 1, 2003; 121(12): 1745 - 1751. [Abstract] [Full Text] [PDF]

				S. Cellek, N. A. Foxwell, and S. Moncada Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats Diabetes, September 1, 2003; 52(9): 2353 - 2362. [Abstract] [Full Text] [PDF]

				R. A. Kowluru Effect of Reinstitution of Good Glycemic Control on Retinal Oxidative Stress and Nitrative Stress in Diabetic Rats Diabetes, March 1, 2003; 52(3): 818 - 823. [Abstract] [Full Text] [PDF]

				R. A. Kowluru and P. Koppolu Termination of Experimental Galactosemia in Rats, and Progression of Retinal Metabolic Abnormalities Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3287 - 3291. [Abstract] [Full Text] [PDF]

				P. F. Kador, Y. Takahashi, Y. Akagi, H. Neuenschwander, W. Greentree, P. Lackner, K. Blessing, and M. Wyman Effect of Galactose Diet Removal on the Progression of Retinal Vessel Changes in Galactose-Fed Dogs Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1916 - 1921. [Abstract] [Full Text] [PDF]

				A. Fornoni, L. J. Striker, F. Zheng, and G. E. Striker Reversibility of Glucose-Induced Changes in Mesangial Cell Extracellular Matrix Depends on the Genetic Background Diabetes, February 1, 2002; 51(2): 499 - 505. [Abstract] [Full Text] [PDF]

				D. D. Gutterman Vascular Dysfunction in Hyperglycemia: Is Protein Kinase C the Culprit? Circ. Res., January 11, 2002; 90(1): 5 - 7. [Full Text] [PDF]

				T. S. Kern and R. L. Engerman Pharmacological Inhibition of Diabetic Retinopathy: Aminoguanidine and Aspirin Diabetes, July 1, 2001; 50(7): 1636 - 1642. [Abstract] [Full Text] [PDF]

				Y. Matsubara, M. Murata, T. Maruyama, M. Handa, N. Yamagata, G. Watanabe, T. Saruta, and Y. Ikeda Association between diabetic retinopathy and genetic variations in alpha 2beta 1 integrin, a platelet receptor for collagen Blood, March 1, 2000; 95(5): 1560 - 1564. [Abstract] [Full Text] [PDF]

				The Diabetes Control and Complications Trial/Epide Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy N. Engl. J. Med., February 10, 2000; 342(6): 381 - 389. [Abstract] [Full Text] [PDF]

				The Diabetes Control and Complications Trial Resea The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus N. Engl. J. Med., September 30, 1993; 329(14): 977 - 986. [Abstract] [Full Text]

				D. M. Nathan Long-Term Complications of Diabetes Mellitus N. Engl. J. Med., June 10, 1993; 328(23): 1676 - 1685. [Full Text]

				Sandra. Hoops Renal and Retinal Complications in Insulin-Dependent Diabetes Mellitus: The Art of Changing the Outcome The Diabetes Educator, January 1, 1990; 16(3): 221 - 230. [PDF]

				C. G. Hernandez The Pathophysiology of Diabetes Mellitus: An Update The Diabetes Educator, January 1, 1989; 15(2): 162 - 169. [PDF]

				P. Chellan and R. H. Nagaraj Early Glycation Products Produce Pentosidine Cross-links on Native Proteins. NOVEL MECHANISM OF PENTOSIDINE FORMATION AND PROPAGATION OF GLYCATION J. Biol. Chem., February 2, 2001; 276(6): 3895 - 3903. [Abstract] [Full Text] [PDF]